Paxil Regulatory Litigation May Affect Exclusivity, FDA “Ministerial” Role
Ivax' declaratory judgment actions against Paxil maker GlaxoSmithKline could threaten Apotex' 180-day exclusivity on paroxetine
Ivax' declaratory judgment actions against Paxil maker GlaxoSmithKline could threaten Apotex' 180-day exclusivity on paroxetine